Skip to content

Mehdi Mahammadli

4 papers in the library · 61 citations · publishing 2022-2024

Papers

Sort Most recent Most cited

Experiences of psychedelic drug use among people with psychotic symptoms and disorders: Personal growth and mystical experiences

Journal of Psychedelic Studies July 31, 2024 Joseph T. la Torre, Jade Gallo, Mehdi Mahammadli et al. 6 citations

Individuals with a history of psychotic experiences and disorders such as schizophrenia, and mood disorders with psychotic features tend to be excluded from psychedelic-assisted therapy research and treatment programs, despite minimal research demonstrating heightened risk of adverse effects for this group. Participants (n = 100) were asked to complete an online, retrospective survey that asked...

Exploring effects and experiences of ketamine in group couples therapy

Journal of Psychedelic Studies May 6, 2024 Mark Cornfield, S. Mcbride, Joseph T. la Torre et al. 6 citations

This study contributes to the understanding of the efficacy, safety, and experience of ketamine-assisted therapy. The paper documents how individuals describe the effects of a protocolized and personalized use of ketamine (‘the relational dose’) in the context of group couples therapy based on Imago Relationship Therapy (IRT). Little is known about simultaneously administering ketamine to both...

Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders

International Journal of Mental Health and Addiction April 1, 2024 Joseph T. Torre, Mehdi Mahammadli, Sonya C. Faber et al. 31 citations

Currently, individuals with personal or familial histories of psychopathological experiences of psychosis, psychotic spectrum disorders, bipolar disorder, and similar conditions are excluded from most psychedelic clinical trials, studies, and treatment programs. This study sought to determine why such an exclusion exists, what the implications of the exclusion criteria are, and if there was...

Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychotic Symptoms

Research Square (Research Square) January 25, 2022 Joseph T. la Torre, Mehdi Mahammadli, Kyle T. Greenway et al. 18 citations

Abstract Background Currently, personal or familial histories of psychotic symptoms are exclusionary criteria for most psychedelic clinical trials, studies, and treatment programs. This study sought to determine why such an exclusion exists, what the implications of the exclusion criteria are, and if there was agreement in expert opinion. Methods In-depth interviews with 12 experts in the...